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Background: The nationwide integration of palliative care best practices into general care settings is challenging
but important in improving the quality of palliative care. This is why the Dutch National Quality Improvement
Programme for Palliative Care has recently been launched. This four-year programme consists of about 70
implementation trajectories of best practices. A large evaluation study has been set up to evaluate this national
programme and separate implementation trajectories.
Methods/Design: This paper presents the protocol of the evaluation study consisting of a quantitative effect
evaluation and a qualitative process evaluation. The effect evaluation has a pre-test post-test design, with
measurements before implementation (month 0) and after implementation (month 9) of a best practice. Patients
are eligible if they have a life expectancy of less than six months and/or if they are undergoing palliative treatment
and provided they are physically and mentally capable of responding to questionnaires. Bereaved relatives are
eligible if they have been involved in the care of a deceased patient who died after a sickbed between six weeks
and six months ago. Three types of measurement instruments are used: (1) numerical rating scales for six symptoms
(pain, fatigue, breathlessness, obstipation, sadness and anxiety), (2) the Consumer Quality Index Palliative
Care - patient version and (3) the version for bereaved relatives.
The process evaluation consists of analysing implementation plans and reports of the implementation, and
individual and group interviews with healthcare professionals. This will be done nine to eleven months after the
start of the implementation of a best practice.
Discussion: This mixed-method evaluation study gives more insight into the effects of the total programme and
the separate implementation trajectories. However, evaluation of large quality improvement programmes is
complicated due to changing, non-controlled environments. Therefore, it is important that an effect evaluation is
combined with a process evaluation.
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Death comes to us all. Nowadays, acute deaths due to
infectious diseases have largely been replaced by non-
sudden deaths, caused by e.g. cancer, cardiovascular dis-
eases and dementia [1]. Therefore, the need for palliative
care is increasing. High-quality palliative care is import-
ant in improving the quality of life of patients and their
families facing the problems associated with a life-
threatening disease [2]. Since the 1990s, the Dutch gov-
ernment has consistently invested in the optimization of
palliative care, and nowadays many best practices are
available in the Netherlands. 'Best practices' are defined
in this paper as practices, often developed among small
groups of patients and professionals, that contribute to
the improvement of palliative care and that are transfer-
rable to other settings. Some examples of best practices
in the Netherlands are:
The Dutch version of the Liverpool Care Pathway for
the Dying Patient [3]. The pathway was developed to
aid members of a multi-disciplinary team in matters re-
lating to continuing or discontinuation of treatments
and regarding comfort measures during the last days
and hours of a patient's life.
PaTz – a systematic approach to optimize palliative
care based on the Gold Standard Framework (http://
www.goldstandardsframework.org.uk/). Its elements
include collaborative meetings of general practitioners
and community nurses, the timely identification of
patients in need of palliative care and the drafting of an
advance care plan [4].
Informare, a tailored method that enables health care
professionals to provide timely information about
palliative care to patients and relatives [4].
‘Signal box for nursing assistants’, a tool that enables
nursing assistants to identify palliative care needs in
their patients and pass this information on to other
professionals [4].
These best practices are known for their contribution
to high-quality palliative care, although so far most of
the knowledge about the effects of these best practices
on the quality of palliative care is practice-based rather
than evidence-based. At the moment, most evidence is
available with regard to the Dutch version of the
Liverpool Care Pathway (LCP) for the Dying Patient and
regarding PaTz. Research has indicated that use of the
Dutch version of the LCP leads to a decrease in the
symptom burden for patients in the last days of life, a
decrease in the grief burden for relatives and an im-
provement in the documentation of care [5-7]. Further-
more, a recent review showed that the Gold Standard
Framework (the British equivalent of PaTz) improves
processes in general practice, co-working and the qualityof palliative care. Although the direct impact on patients
and carers is unknown at present, the Gold Standard
Framework has considerable potential to improve pallia-
tive primary care [8].
Although large-scale implementation of such best
practices appears to be important for improving pallia-
tive care, implementation in general health care settings
(e.g. general hospitals, general practices, residential eld-
erly care and home care) is challenging, e.g. because pro-
fessionals in general health care settings are often not
specialized in palliative care and often provide care to a
variety of patient categories. Moreover, hospital settings
in particular are traditionally strongly focused on cure
and life prolongation, which influences how palliative
care needs are attended to [9].
National quality improvement programme for palliative
care
The Dutch National Quality Improvement Programme
for Palliative Care was launched in 2012 with the aim of
promoting the implementation of best practices in gen-
eral health care settings. This four-year programme re-
ceives financial and practical support from ZonMw (The
Netherlands Organisation for Health Research and De-
velopment) and was commissioned by the Dutch Minis-
try of Health. The programme’s key objectives are to
promote that:
 Patients die at their preferred place.
 Patients and relatives feel they are in control
regarding palliative care.
 Patients and relatives see palliative care as being
coordinated.
 Patients and relatives feel care to be concordant
with their needs, preferences and values.
 Patients and relatives receive care for their needs in
the physical, psychosocial and spiritual domains.
This programme enables care organizations to im-
prove their palliative care by implementing one or more
of the available best practices. The best practices are
pre-selected by an independent committee of experts,
professionals and patient representatives, taking account
of the available evidence, the usability and the transfer-
ability of the best practice to general health care settings.
The committee assesses potential new best practices
every year to include in the National Quality Improve-
ment Program Palliative Care. The nine best practices
that are currently pre-selected for implementation are
listed in Additional file 1.
Every year during the programme period (2012–2016),
there is a call for applications. Representatives of re-
gional networks of palliative care providers are invited to
choose a specific best practice from the pre-selected list
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trajectory. Each year, financial support is given by
ZonMw for approximately 17 implementation trajector-
ies. The grant applications are assessed by an independ-
ent quality working group. The criteria for granting this
support include the requirement that the applicant must
be a representative of the regional palliative care net-
works, the care organizations involved must reach a sub-
stantial number of patients with palliative care needs
and the best practice chosen must be implemented
within one year [10].
It is important to determine the effects of the Na-
tional Quality Improvement Programme for Palliative
Care, since a lot of professionals and financial re-
sources are involved and ultimately patients and
relatives must benefit from this great effort. Other
large-scale improvement programmes have already
been implemented and evaluated in other domains, e.
g. regarding safety in health care and social care
[11-15]. However, so far such large-scale programmes
are a new feature within palliative care. Earlier evalu-
ations in other health care domains not only focused
on the effectiveness of the programmes but also de-
scribed the implementation processes in order to en-
able an understanding of how the programmes take
shape in practice, as well as of barriers and facilita-
tors. Such a process evaluation can be referred to as
opening the ‘black box’ of interventions [16], which is
important in increasing the likelihood that interven-
tions will continue to be used in practice after the re-
search has finished. In palliative care too, it is
important to bridge the gap between research and
practice [17,18] and to maximize the likelihood of the
long-term adoption of quality improvement projects
in practice [19]. Therefore, it is important to describe
both the effects and the process of this large-scale
implementation of palliative care best practices.
Objectives
This paper presents the study protocol of the evaluation
study. The primary objective of this study is:
 To gain insight into the effects of the National
Quality Improvement Programme for Palliative
Care as a whole on the quality of palliative care
at a national level.
Its secondary objectives are:
 To gain insight into the effects of the separate
implementation trajectories of best practices on
the quality of palliative care within the
participating regional palliative care networks or
organizations. To elucidate the measured effects by describing the
implementation process and the barriers and
facilitators within the separate implementation
trajectories.
The specific research questions being addressed in the
evaluation study are as follows:
1. What are the effects of the National Quality
Improvement Programme for Palliative Care as a
whole on the quality of palliative care? More
specifically, what are the programme’s effects on:
a. The percentage of patients who die in their
preferred place?
b. The extent to which patients and relatives feel in
control regarding palliative care?
c. The extent to which patients and relatives
experience well-coordinated palliative care?
d. The extent to which patients and relatives feel
that the palliative care is concordant with their
preferences and values and meets their needs in
the physical, psychosocial and spiritual domains?
2. What are the effects of the separate implementation
trajectories on the quality of palliative care at the
level of the regional palliative care networks or care
organizations involved? (with equivalent
subquestions to questions 1a to 1d)
3. How and to what extent are the best practices
implemented? More specifically:
a. Does the implementation of the best practices
take place as planned?
b. What barriers and facilitators are there for the
implementation of the best practices and what
conditions have been created to ensure the best
practices are maintained?
c. Are there any other factors or developments –
inside or outside the participating organizations
– that might have contributed to the measured
effects of the programme as a whole or within
the separate implementation trajectories?Methods
Evaluation study design
The National Quality Improvement Programme can be
considered as a complex intervention involving various im-
plementation trajectories of various best practices within a
continuously changing, uncontrolled environment. There-
fore we opted for a quantitative effect evaluation with a
pre-test post-test design (to answer research questions 1
and 2) in combination with a qualitative process evaluation
with a post-test design (to answer research question 3). The
combination of quantitative and qualitative methods is
considered useful in gaining insight into the effects of the
programme, as well as the implementation processes,
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or external factors that may influence the outcomes.
Study population
All implementation trajectories receiving a grant in the Na-
tional Quality Improvement Programme will participate in
the evaluation study. Within the participating organiza-
tions, data will be collected from patients and bereaved rel-
atives (see Figure 1). In implementation trajectories with
more than five participating organizations, a purposive
sample will be selected of care organizations with the high-
est number of patients meeting the inclusion criteria and
representing all the different settings involved in the spe-
cific implementation trajectory.
An existent set of quality indicators measured among pa-
tients and bereaved relatives will be used for the effect
evaluation [20]. The inclusion and exclusion criteria for pa-
tients and bereaved relatives are described in Additional
files 2 and 3. Per trajectory we aim to include 15–20 pa-
tients and 30–40 bereaved relatives in each assessment
period. As there are two assessment periods for the ap-
proximately 17 planned trajectories per year, this will result
into a minimum of about 510 participating patients and1 2 3















Figure 1 Organogram of the national quality improvement program1020 participating bereaved relatives per year, which gives a
total number of about 2040 patients and 4080 bereaved rel-
atives over four years.
For the process evaluation, data will be collected
among professionals. For each implementation trajec-
tory, the project manager will be interviewed and a
group interview will be done with other stakeholders in-
volved. Assuming 17 implementation trajectories per
year over four years, this will result in 68 interviews with
project managers and 68 group interviews with
stakeholders.
Effect evaluation
Pre-test and post-test measurements will take place in
the effect evaluation, in month 0 and month 9 respect-
ively (see Figure 2). During these two measurement
months, eligible patients and bereaved relatives will be
asked to participate.
Data collection
In the pre-test and post-test measurements, a set of
quality indicators will be measured [20], making use of

























Figure 2 Chronological overview of one year of the program.
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 The Consumer Quality Index Palliative Care for
patients
 The Consumer Quality Index Palliative Care for
bereaved relatives
Numeric Rating Scales (NRS) will be used to measure
the quality indicators ‘The % of patients with moderate
to severe pain’, ‘The % of patients with moderate to se-
vere fatigue’, ‘The % of patients with moderate to severe
shortness of breath’, ‘The % of patients with moderate to
severe constipation’, ‘The % of patients with moderate to
severe anxiety’ and ‘The % of patients who feel moder-
ately to severely depressed’. These indicators are associ-
ated with one specific programme objective, namely
‘Patients receive care for their needs in the physical and
psychosocial domains’.
Patients will be reminded by one of their health care
professionals to complete the NRS for the six symptoms
(see Table 1) approximately the same time at three con-
secutive days. In principle, the patient will fill in the
NRS scores. Only if the patient is not able to write will
the health care professional assist the patient by writing
down the NRS scores. The completed NRS forms will be
collected by the health care professional after day 3 and
send to the research team at the end of the measure-
ment period.
The Consumer Quality Index Palliative Care (CQ
Index) is a validated questionnaire assessing quality indi-
cators from the perspective of patients and bereaved rel-
atives [21,22]. The quality indicators measured by thisTable 1 Numeric rating scales of 6 symptoms
Symptoms (What number would you give your …symptom… on a
scale of 0 to 10?
No pain 0 1 2 3 4 5 6 7 8 9 10 Much pain





Not obstipated Very obstipated
Not sad Very sad
Not anxious Very anxiousCQ Index are also directly related to the key objectives
of the National Quality Improvement Programme (see
Table 2). CQ index questions for instance concern pa-
tients’ or bereaved relatives’ experiences regarding the
control over palliative care, the coordination of palliative
care, the concordance between the care given and needs,
preferences and values, and the physical, psychosocial
and spiritual care received. In the version for bereaved
relatives, questions are also asked about the actual and
preferred place of death of the patient. The question-
naire version for patients consists of 56 items, while the
version for bereaved relatives consists of 64 questions.
Both questionnaire versions take approximately 30–
45 minutes to complete. For inpatient patients, the ques-
tionnaire will be completed on the basis of an interview
with a trained interviewer. Patients who receive care at
home and bereaved relatives will receive the question-
naire by post to be completed and returned in a reply
envelope to the research team. No reminders will be sent
to non-responding patients, while a reminder will be
sent after two weeks to non-responding bereaved
relatives.
Data analysis
Descriptive statistics (frequencies, percentages and means)
will be used to analyse background characteristics.
The effects of the separate implementation trajectories
(research question 2) will be analysed using descriptive ana-
lyses as well as univariate analyses (with paired t tests or
McNemar’s test). To assess the differences between pre-test
and post-test measurements for the whole programme (re-
search question 1), multilevel analysis will be used, includ-
ing the levels of the participating care networks or care
organizations, and the type of best practice. SPSS, STATA
and ML-WIN will be used for the statistical analysis.
Process evaluation
A qualitative process evaluation will be conducted nine to
eleven months after the start of the implementation in a
separate implementation trajectory (see Figure 2). The
process evaluation will be used to explain the effects found
(or not found) in the effect evaluation and provide insight
into how the best practices are implemented.
Table 2 Key objectives of the national quality improvement program and associated quality indicators, measured with
the CQ index palliative care
Key objectives of the programme Quality indicators measured with CQ index
version for patients
Quality indicators measured with CQ index
version for bereaved relatives
Patients die at their preferred place - *Percentage of patients who died in the location of
their preference
*Extent to which patients in the last month before
their death were in the location of their preference
Patients and relatives feel they are in
control regarding palliative care
*Extent to which patients experience respect for
their autonomy
*Extent to which relatives indicate that the patient
was asked about her/his opinions with regard to end-
of-life decisions
*Extent to which patients receive information
from their caregivers about the expected course
of the disease
*Extent to which direct relatives received information
about the advantages and disadvantages of various
types of treatment
*Extent to which patients receive information
about the advantages and disadvantages of
various types of treatments
*Extent to which direct relatives received information
that was understandable and unambiguous at the
time of the patient’s death
*Extent to which patients indicate that they
receive understandable explanations
*Extent to which, according to the bereaved relatives,
their autonomy was respected
*Extent to which direct relatives were informed about
the possibilities of aftercare
Patients and relatives see palliative care
as being coordinated
*Extent to which patients know who the contact
person is for the care
*Extent to which the bereaved relatives knew who
the contact person was for the care
*Extent to which patients experience expertise of
caregivers and continuity of care
*Extent to which direct relatives perceived expertise
of caregivers and continuity of care
*Extent to which patients receive contradictory
information
Patients and relatives feel care to be
concordant with their needs, preferences
and values
*Extent to which patients are satisfied with
“politeness” and “being taken seriously” by
caregivers
*Extent to which the direct relatives felt that they
were treated well in all respects by the caregivers
*Extent to which patients experience respect for
their privacy
*Extent to which direct relatives considered that the
patient had the opportunity to be alone
*Extent to which patients indicate that caregivers
respect their life stance
*Extent to which the direct relatives had the
opportunity to be alone with their relative
*Percentage of patients who receive medical aids
soon enough
Patients and relatives receive care for
their needs in the physical, psychosocial,
and spiritual domains
*Extent to which patients receive support for their
physical symptoms (pain, fatigue, shortness of
breath and constipation)
*Extent to which relatives indicate that the patient
had access to a counselor for spiritual problems
*Extent to which patients receive help with
physical care
*Extent to which relatives indicate that the patient
received support with preparations for saying
goodbye
*Extent to which patients receive attention from
their caregivers
*Extent to which relatives indicate that there was
attention for the psychosocial and spiritual well-being
of the patient
*Extent to which patients receive support when
they feel anxious or feel depressed
*Extent to which, according to the direct relatives,
attention was paid to their own psychosocial and
spiritual well-being
*Extent to which patients indicate that they have
access to a counsellor for spiritual problems
*Extent to which direct relatives felt supported by the
caregivers immediately after the patient’s death
*Extent to which a final conversation or discussion
was held to evaluate the care and treatment
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First, an analysis of relevant documents (e.g. implementa-
tion plans, and interim and final reports of the separate im-
plementation trajectories) will provide insight into the
implementation process. Second, we will conduct individualsemi-structured interviews with the project managers of
each trajectory. The topic list for the interviews will include
questions on whether the best practice was implemented as
planned, what the barriers and facilitators were for the
implementation, what implementation strategies were used
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been successful and effective. Third, for each implementa-
tion trajectory we will organize semi-structured group in-
terviews with relevant other stakeholders (such as
representatives of clients’ participation councils, nurses,
doctors or other care professionals involved). A similar
topic list as described for the individual interviews will be
used for the group interviews. Both individual and group
interviews will be audio-recorded.
Data analysis
The audio-recorded interviews will be transcribed verba-
tim. Subsequently a qualitative thematic analysis will be
done, starting immediately after conducting and tran-
scribing the individual and group interviews for a spe-
cific implementation trajectory. All relevant documents
and interviews will be coded, analysed and discussed by
at least two researchers. The coding process will be in-
ductive, in the sense that themes and associated codes
will emerge from the interview data through repeated
comparison of relevant fragments within and between
interviews. The coding process will be supported by the
software package MAXQDA [23].
Feedback and dissemination
The project manager and other stakeholders in a specific
implementation trajectory will receive internal feedback
reports on the results of the effect evaluation (after the pre-
test measurements as well as after the post-test measure-
ments) within two months after the measurement period.
The prospect of getting feedback reports is important in
order to increase the commitment of the project managers
and stakeholders to participating in the measurements. In
addition, the feedback reports will motivate the profes-
sionals involved to further improve the quality of their care,
where needed.
Furthermore, interim reports about the progress of the
programme as a whole will be published; these will also
be made available to the general public. Also, additional
international scientific publications about the effects and
implementation of the programme are planned.
Ethical considerations
The study protocol has been approved by the Medical Eth-
ical Committee of the University Medical Center in Leiden,
the Netherlands. Written informed consent of all patients
will be obtained for the assessment of their symptoms and
inpatients also consented with the Consumer Quality Index
Palliative Care questionnaire, as it has to be completed by a
trained interviewer. Patients who are at home and bereaved
relatives received this questionnaire by post and for this no
written informed consent is needed. Furthermore, in data
collection and analyses procedures we follow the rules of
Dutch Personal Data Protection Act (Wet BeschermingPersoonsgegevens). All personal identifiers will be removed
or disguised in the analysis process to safeguard the privacy
and anonymity of participants.
Discussion
This evaluation study provides a unique chance to gain
insight into the effects and implementation process of the
National Quality Improvement Programme for Palliative
Care and its separate implementation trajectories. The im-
plementation of best practices within the framework of a
long-term, broad nationwide programme can be considered
as a complex intervention within a continuously changing,
uncontrolled environment. Complex interventions are de-
scribed by Pawson et al. as long journeys, embedded in
multiple social systems, which are open and adaptive [24].
These characteristics also hold for the National Quality Im-
provement Programme for Palliative Care, which consists
of the implementation of multiple best practices in different
settings and with different starting points over a four-year
period. Our programme is also relatively open and adaptive,
for example as a result of the feedback reports and interim
reporting. Feedback reports give the organizations insight
into the current state of the quality of palliative care within
their organization and might lead to additional actions to
improve palliative care.
Randomised controlled designs (RCT) are often not
applicable and feasible for the evaluation of complex in-
terventions such as national quality improvement pro-
grammes [25,26]. When an RCT is not possible - as is
the case in the evaluation of the National Quality Im-
provement Programme for Palliative Care - it is import-
ant to use a mixed-method design and to combine
quantitative effect measurements with a qualitative
process evaluation. Qualitative process evaluations, e.g.
based on the qualitative analysis of interviews and docu-
ments, can help understand the effects (or sometimes
the lack of effects) of interventions. Process evaluations
are helpful in elucidating the implementation process
and the interventions actually delivered (opening the
‘black box’) and in identifying other possible factors that
may have contributed to the measured outcomes. One
such factor may be an ‘investigation effect’ caused by the
feedback reports. Therefore, during the process evalu-
ation we will pay extra attention to possible additional
actions of care organizations prompted by these feed-
back reports.
Evaluating complex interventions among patients with a
limited life expectancy and among bereaved relatives is par-
ticularly challenging for researchers. In such populations,
researchers have to take extra account of the burden of
measurement for respondents, although many of them are
willing to contribute to scientific research [27,28]. An add-
itional challenge in our study in particular is the fact that
palliative care patients are often 'scattered' throughout the
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the National Quality Improvement Programme for Pallia-
tive Care, i.e. to improve palliative care in general health
care settings (like hospitals or home care), groups of pa-
tients with palliative care needs are less concentrated than
in research within hospices, for instance, or specialist pallia-
tive care units. This means that an extra effort has to be
made for the recruitment of patients and relatives as well as
for informing all the professionals involved.
Additional files
Additional file 1: Currently selected ‘best practices’.
Additional file 2: Inclusion and exclusion criteria for patients.
Additional file 3: Inclusion and exclusion criteria for bereaved
relatives.
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